Enhanced protective efficacy of Borrelia burgdorferi BB0172 derived-peptide based vaccine to control Lyme disease

Vaccine
Wisam Salim HassanMaria D Esteve-Gasent

Abstract

Lyme disease (LD) accounts for over 70% of tick-borne disease reported in the United States. The disease in humans is characterized by skin rash, arthritis, cardiac and neurological signs. Vaccination is the most efficient preventive measure that could be taken to reduce the incidence of the LD worldwide; however, at present no vaccine is available. In this study, evaluation of the Borrelia burgdorferi BB0172-derived peptide (PepB) in conjugated formulations was investigated as a vaccine candidate in murine model of LD. In brief, PepB was conjugated to the Cross-Reacting Material 197 (CRM197) and to Tetanus Toxoid heavy chain (TTHc) molecules, and subsequently used to immunize C3H/HeN mice. Following the challenge with 105 spirochetes/mouse via subcutaneous inoculation, TTHc:PepB construct showed protection in 66% of the immunized animals. Hence, to further evaluate the efficacy of TTHc:PepB, immunized mice were challenged with B. burgdorferi using the tick model of infection. The outcome of this experiment revealed that serum from TTHc:PepB immunized mice was borrelicidal. After tick infection, bacterial burden was significantly reduced (over 70%) in vaccinated animals when compared with the control groups regardless of whethe...Continue Reading

References

May 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P ParronchiS Romagnani
Feb 1, 1984·Infection and Immunity·A J SheppardM Hughes
Jul 1, 1984·Infection and Immunity·A G BarbourS F Hayes
Oct 1, 1995·The American Journal of Tropical Medicine and Hygiene·A M De Silva, E Fikrig
Nov 26, 1993·Science·M F BachmannR M Zinkernagel
Jun 11, 1993·Science·A G Barbour, D Fish
Aug 1, 1997·Infection and Immunity·I KangL K Bockenstedt
Oct 22, 1998·The Pediatric Infectious Disease Journal·P T Heath
Mar 18, 2000·The Journal of Infectious Diseases·B M Diethelm-OkitaB M Conti-Fine
Jan 31, 2003·European Journal of Immunology·Andrea JegerlehnerMartin F Bachmann
May 23, 2003·Infection and Immunity·Chad S BrooksDarrin R Akins
May 17, 2005·Anais Da Academia Brasileira De Ciências·Christopher Jones
Jul 29, 2005·Nature·Nandhini RamamoorthiErol Fikrig
Sep 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hervé TettelinClaire M Fraser
Mar 16, 2007·Clinical and Vaccine Immunology : CVI·Christopher G Earnhart, Richard T Marconi
Apr 17, 2007·ACS Chemical Biology·Erik B PufferLaura L Kiessling
Mar 25, 2008·Journal of Bacteriology·Siddharth Y Srivastava, Aravinda M de Silva
Sep 5, 2008·Current Protocols in Microbiology·Melissa J Caimano
Dec 2, 2008·Molecular Microbiology·Maria D Esteve-GassentJ Seshu
Jul 6, 2010·Chembiochem : a European Journal of Chemical Biology·Qian LiJeffrey C Gildersleeve
Sep 28, 2010·Applied and Environmental Microbiology·Dania Richter, Franz-Rainer Matuschka
Oct 30, 2010·Immunity·Alessandro Sette, Rino Rappuoli

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.